Pharma Firms Pile Pressure on the UK as Trump's Drug Pricing Order Looms

Pharma firms pile pressure on the UK as Trump's drug pricing order looms

A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.

Trump Announces New Plan to Lower Prescription Drug Prices as Pharma Fights to Kill Discounts › American Greatness

President Trump is looking to take swift action to bring down prices on groceries and prescription drugs, the White House announced this week. The President is […] Source

U.S. pressures U.K. as pharma pauses investments there

Today's biotech news has an FDA retreat from expert panels, Eli Lilly pausing plans and AstraZeneca shelving a vaccine site in U.K., etc.